Informa Healthcare

SHERPA: Yellow

People

  1. Kelsen
    Kelsen
  2. Ilson
    Ilson
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Kemeny
    Kemeny
  6. Bajorin
    Bajorin
  7. Gollub
    Gollub
  8. Heelan
    Heelan
  9. Iacobuzio-Donahue
    Iacobuzio-Donahue
  10. Ku
    Ku

Groups

  1. Center for Pancreatic Cancer Research (9)
  2. Department of Medicine (9)
  3. Gastrointestinal Oncology Service (9)
  4. Solid Tumor Oncology Division (9)
  5. Population Sciences Research Program (2)
  6. Body Imaging Service (1)
  7. Clinical Genetics Service (1)
  8. DigITs Research Group (1)
  9. GSK Faculty (1)
  10. Genitourinary Oncology Service (1)
Search Within
  1. "David Kelsen"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (2)
Groups
  1. Center for Pancreatic Cancer Research (9)
  2. Department of Medicine (9)
  3. Gastrointestinal Oncology Service (9)
  4. Solid Tumor Oncology Division (9)
  5. Population Sciences Research Program (2)
  6. Body Imaging Service (1)

More Groups

People
  1. David Kelsen (9)
  2. David Ilson (5)
  3. Eileen O'Reilly (5)
  4. Leonard Saltz (4)
  5. Nancy Kemeny (2)
  6. Alfred Cohen (1)

More People

Years
  1. 2016 (1)
  2. 2009 (1)
  3. 2003 (1)
  4. 2000 (1)
  5. 1999 (2)
  6. 1995 (1)

More Years

Publications
  1. Cancer Investigation (8)
  2. Expert Review of Gastroenterology and Hepatology (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic instability in pancreatic adenocarcinoma: A new step towards precision medicine and novel therapeutic approaches
    Journal Article

    Sahin, I. H.; Lowery, M. A.; Stadler, Z. K.; Salo-Mullen, E.; Iacobuzio-Donahue, C. A.; Kelsen, D. P.; O'Reilly, E. M.
    Expert Review of Gastroenterology and Hepatology (2016)

    Fulltext@MSK | Save
  • Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors
    Journal Article

    Ku, G. Y.; O'Reilly, E. M.; Saltz, L. B.; Schrag, D.; Maki, R. G.; Kelsen, D. P.; Ilson, D. H.
    Cancer Investigation (2009)

    Fulltext@MSK | Save
  • Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancer
    Journal Article

    Anderson, S. E.; O'Reilly, E. M.; Kelsen, D. P.; Ilson, D. H.
    Cancer Investigation (2003)

    Fulltext@MSK | Save
  • Gemcitabine and irinotecan in advanced gastrointestinal malignancies
    Meeting Abstract

    O'Reilly, E. M.; Schwartz, G. K.; Ilson, D. H.; Kemeny, N. K.; Saltz, L. B.; Kelsen, D. P.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • A phase II trial of cisplatin and irinotecan in patients with advanced esophageal cancer
    Meeting Abstract

    Ilson, D.; Saltz, L.; Enzinger, P.; Huang, Y.; Gollub, M.; Kelsen, D.
    Cancer Investigation (1999)

    Fulltext@MSK | Save
  • A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesothelioma
    Journal Article

    O'Reilly, E. M.; Ilson, D. H.; Saltz, L. B.; Heelan, R.; Martin, L.; Kelsen, D. P.
    Cancer Investigation (1999)

    Fulltext@MSK | Save
  • Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer
    Journal Article

    Minsky, B. D.; Cohen, A. M.; Enker, W. E.; Kelsen, D. P.; Kemeny, N.; Frankel, J.
    Cancer Investigation (1995)

    Fulltext@MSK | Save
  • A phase I trial of combination chemotherapy employing carboplatin, vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors
    Journal Article

    Bajorin, D.; Kelsen, D. P.
    Cancer Investigation (1990)

    Fulltext@MSK | Save
  • Phase I study of elliptinium (2-n-methyl-9-hydroxyellipticinium)
    Journal Article

    Einzig, A. I.; Gralla, R. J.; Leyland-Jones, B. R.; Kelsen, D. P.; Cibas, I.; Lewis, E.; Greenberg, A. E.
    Cancer Investigation (1985)

    Fulltext@MSK | Save